v3.22.2.2
Acquisitions and Divestitures - HRA Narrative (Details)
$ in Millions, € in Billions
3 Months Ended 5 Months Ended 9 Months Ended
Apr. 29, 2022
EUR (€)
Apr. 29, 2022
USD ($)
Oct. 01, 2022
USD ($)
Oct. 01, 2022
USD ($)
Oct. 01, 2022
USD ($)
Oct. 02, 2021
USD ($)
Dec. 31, 2021
USD ($)
Business Acquisition [Line Items]              
General transaction costs           $ 65.5  
Goodwill carrying amount     $ 3,428.9 $ 3,428.9 $ 3,428.9   $ 2,999.4
Goodwill acquired         618.1    
CSCA              
Business Acquisition [Line Items]              
Goodwill carrying amount     1,996.2 1,996.2 1,996.2   1,902.4
Goodwill acquired         93.3    
CSCI              
Business Acquisition [Line Items]              
Goodwill carrying amount     1,432.7 1,432.7 1,432.7   $ 1,097.0
Goodwill acquired         524.8    
HRA Pharma              
Business Acquisition [Line Items]              
Outstanding equity interest acquired (percent)   100.00%          
Binding offer for acquisition € 1.8 $ 1,945.6          
Net sales since acquisition       128.7      
Net loss since acquisition       26.3      
Cost of goods sold since acquisition       10.2      
Amortization of intangible assets since acquisition       38.8      
General transaction costs     0.6   43.9    
Goodwill carrying amount   618.1 1.9 1.9 1.9    
Inventories   37.3 1.2 1.2 1.2    
Deferred income taxes   169.0 1.1 1.1 1.1    
Accounts payable   43.4 1.1 1.1 1.1    
Other non-current liabilities   $ 10.6 $ 0.7 $ 0.7 $ 0.7    
HRA Pharma | Trademarks, trade names, and brands | Minimum              
Business Acquisition [Line Items]              
Useful life of intangible assets 20 years 20 years          
HRA Pharma | Trademarks, trade names, and brands | Maximum              
Business Acquisition [Line Items]              
Useful life of intangible assets 26 years 26 years          
HRA Pharma | Developed product technology | Minimum              
Business Acquisition [Line Items]              
Useful life of intangible assets 8 years 8 years          
HRA Pharma | Developed product technology | Maximum              
Business Acquisition [Line Items]              
Useful life of intangible assets 21 years 21 years          
HRA Pharma | Distribution networks | Minimum              
Business Acquisition [Line Items]              
Useful life of intangible assets 2 years 2 years          
HRA Pharma | Distribution networks | Maximum              
Business Acquisition [Line Items]              
Useful life of intangible assets 23 years 23 years